The present disclosure relates to novel compounds of formula (I) which are useful as inhibitors of endoplasmic reticulum aminopeptidases (ERAP), in particular as inhibitors of ERAP2. The disclosure also relates to the therapeutic use of these compounds, in particular the use of these compounds in the treatment or prophylaxis of proliferative disorders, autoinflammatory disorders and autoimmune disorders.
本公开涉及一种新型化合物,其
化学式为(I),可用作内质网
氨肽酶(ERAP)的
抑制剂,特别是ERAP2的
抑制剂。本公开还涉及这些化合物的治疗用途,特别是这些化合物在治疗或预防增生性疾病、自身免疫性疾病和自身免疫性疾病方面的应用。